Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03116971
Title Phase Ib/II Study of M3814 With Etoposide and Cisplatin in Small Cell Lung Cancer (SCLC) Extensive Disease (ED)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.

lung small cell carcinoma


Cisplatin + Etoposide + Peposertib


Age Groups: adult | senior
Covered Countries USA | ITA | ESP | DEU | CAN | BEL

No variant requirements are available.